Clinics Now Filing Claims Against NECC Over Fungal Meningitis Outbreak
According to The Tennessean, an outpatient surgical center has filed a $1.17 billion claim against the New England Compounding Center (NECC), which is the pharmacy linked to the deadly fungal meningitis outbreak that swept the country in 2012 and 2013.
The newspaper reported that dozens of patients were injected with fungus-tainted steroids at the Saint Thomas Outpatient Neurosurgical Center. Now, the Nashville-based clinic is seeking damages from NECC.
NECC filed for bankruptcy following the outbreak, which killed 16 people in Tennessee. As of last week, there were 2,931 lawsuits filed by victims from all over the country against NECC.
“The claims were filed in U.S. Bankruptcy Court in Boston in the pending case of the [NECC], the firm blamed by state and federal regulators for the meningitis outbreak,” the Tennessean reported.
Because of the bankruptcy, there may be a limited amount of money available to victims of the outbreak.
Investigators discovered frightening conditions in an NECC plant following the outbreak, which included the alleged growth of black mold.
Our defective drug attorneys at the law firm of Zoll, Kranz & Borgess, LLC represent victims and the families of victims injured or killed because of defective drugs from compounding pharmacies. Contact us at (888)841-9623 for a free consultation.
Zoll & Kranz, LLC – Defective Medical Drug and Device Lawyers